Our results (Figure 5) indicate that treatment with PKC-ι specific siRNA also inhibited PKC-ζ in both breast cancer cell lines, which supports the theory that PKC-ι plays a role in regulating PKC-ζ. Here, PRKCI is linked to breast carcinoma.